RxDoctor Payments Data

Hasan Dosluoglu, MD

Vascular Surgery · Buffalo, NYNPI 1629186515

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,090 of the $3,801 with a category attached, or 81.3%. 20 manufacturers reported payments, led by Silk Road Medical, Inc. at 24.6% of the total. Reporting peaked in 2019 at $1,023 and has fallen 52.8% since, to $483 in 2025. That places this record below the midpoint for vascular surgery clinicians in NY, where the typical reported total is $4,841.

$3,801in general payments, 2019–2025

Across 55 payments — averaging $69.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Silk Road Medical, Inc.$934
  • Shape Memory Medical Inc.$672
  • W. L. Gore & Associates, Inc.$668
  • Abbott$301
  • Medtronic$287
  • Inari Medical, Inc.$255
  • plus $684 from 14 others
$127,598in research payments, 2019–2025

Across 38 payments — averaging $3357.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Tactile Systems Technology Inc$82K
  • Shape Memory Medical Inc.$37K
  • Endologix LLC$9K

What the payments were for

  • Travel & lodging$71119%
  • Food & beverage$3,09081%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,801 in reported general payments places this provider in the 40th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York

Medicare billing

Part B allowed, 2024
$31,991
Medicare patients
73
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →